PRA International Opens New Office in South Korea

Larger office meets growing project needs in the region

RALEIGH, N.C., Nov. 2 /PRNewswire/ -- PRA International, a leading Clinical
Research Organization, announces the opening of a new office facility in
Seoul, South Korea. To accommodate rapid growth and further broaden PRA's
ability to deliver clinical service excellence, the company has moved its
Seoul, South Korea office to a larger, more centrally located facility.

Situated in the well-developed Gangnam area of Seoul, PRA's new office is
conveniently located at the Samsung subway station and very close to the City
Airport Terminal. In the past several months PRA has experienced substantial
growth in South Korea based on increasing customer and project needs. The
need for a larger office space was met with the move to the new facilities on
Monday, 26 October 2009.

South Korea is widely regarded as the third most important pharmaceutical
market in Asia and as one of the most important Asian countries for clinical
studies to support new drug registrations. "The increasing demand for study
work in South Korea drove the need for increased capacity," said Dr. Ludger
Langer, PRA's Vice President - Clinical Operations, Europe, Asia-Pacific,
Africa. "We are now better positioned to meet the continued needs of our
customers in this region."

In moving the office to the Gangnam area, PRA will have better access to the
study institutions in Seoul and can provide greater convenience to sponsors
who visit the area. "The Gangnam area location will enable PRA to continue to
attract the best qualified and most experienced clinical research personnel to
join the rapidly expanding PRA Korea team," noted Edward Ian, Senior Director
of Clinical Operations, PRA - Asia Pacific.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6
continents and provides services through all phases of clinical development.
PRA performs studies in all therapeutic areas, with specialization in
oncology, neurosciences, respiratory/allergy, cardiovascular and infectious
diseases. PRA has supported over 2,100 clinical trials through its 36 global
offices.

PRA's therapeutic expertise, global reach and project experience, combined
with extensive local knowledge and our differentiating PERSONAL ELEMENT enable
our project teams to deliver consistent and on time performance for our
clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that
true client service comes only from trained, empowered and dedicated employees
who are encouraged to use innovation and their personal commitment to
accelerate the development life cycle.

To learn more about PRA International, please visit www.PRAinternational.com,
email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919)
786-8200. Pharmaceutical Research Associates South Korea is located at:

20F, Trade Tower, 159, Samsung-1-dong
Gangnam-gu,
Seoul,135-729, Korea
TEL: +82-2-585-8155
FAX: +82-2-585-3055

SOURCE PRA International

Roger Boutin, Director of Marketing , PRA International, Inc.,
+1-434-951-3924